Results 21 to 30 of about 169,346 (179)
, 2016 The plasma from individuals with normal BMI (n = 17) and low BMI (n = 23, of which 9 were moderately malnourished and 14 were severely malnourished) was tested by ELISA for the levels of IL-8.
J. Raynes (3070401) +16 more
core +1 more source
Tuberculosis after anti-TNF therapy [PDF]
Clinical Rheumatology, 2009 Dear Editor We read with interest the recent article by Elbek et al. [1] assessing the risk of tuberculosis in patients treated with anti-TNF therapy. The study reported that tuberculin test positivity in the area of their study was quite frequent (77.9%) and that males more frequently had positive tests.
Pamuk, Omer Nuri, Donmez, Salim
openaire +2 more sources
Efficacy of the first and subsequent courses of anti-TNF therapy in patients with ankylosing spondylitis - results from the Czech National Register ATTRA Skuteczność pierwszego i kolejnych kursów terapii anty-TNF u pacjentów z zesztywniającym zapaleniem s [PDF]
, 2012 S u m m a r y Background: Efficacy of switching of anti-tumour necrosis factor (anti-TNF) in ankylosing spondylitis (AS) in real clinical practice is not fully known.
Reu Ma, Gia Lo
core
Release of TNF-α during myocardial reperfusion depends on oxidative stress and is prevented by mast cell stabilizers [PDF]
, 2003 Objectives: Our study sought to elucidate the role of oxidative stress for shedding of tumor necrosis factor-α (TNF-α) and for activating TNF-α-converting enzyme (TACE).
Welsch, Ulrich +4 more
core +1 more source
anty-filidor/network_diffusion: 0.6.2
, 2022 Python package for simulations of spreading phenomena on complex ...
Michał Czuba
core +1 more source
Bioequivalence studies with anti-TNF biosimilars [PDF]
Expert Opinion on Biological Therapy, 2018 Introduction: Biosimilars, as defined by the European Medicines Agency, have been used in Europe since 2006. The landscape was considerably expanded when the first biosimilar of a monoclonal was approved and introduced in the European market. CT-P13 was developed by Celltrion as an infliximab biosimilar in 2013, not without controversy.
Mercedes Gimeno-Gracia +2 more
openaire +4 more sources
, 2016 TNF-α concentrations were significantly higher in the IR (ischemia-reperfusion) group compared to the Sham-operated group after 4 hours of reperfusion. TNF-α levels were significantly less elevated by Levosimendan treatment after 4 hours of reperfusion ...
Andras Fulop (457266) +7 more
core +1 more source
Rytuksymab – miejsce w leczeniu reumatoidalnego zapalenia stawów
Rheumatology, 2011 Rytuksymab jest przeciwciałem powodującym niszczenie limfocytówB zaangażowanych w proces zapalny w chorobach autoimmunologicznych.W reumatoidalnym zapaleniu stawów jest zalecanyu chorych, u których utrzymuje się aktywny proces zapalny, mimoleczenia ...
Małgorzata Tłustochowicz
doaj
, 2007 Although only 5-10% of patients with asthma are relatively unresponsive to treatment with inhaled corticosteroids, refractory asthma represents an important condition, as these patients suffer considerable morbidity and mortality and consume a ...
Brightling, C +8 more
core +1 more source
anty-filidor/network_diffusion: 0.6.3
, 2022 Python package for simulations of spreading phenomena on complex ...
Michał Czuba
core +1 more source